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INTRODUCTION:  Positron  Emission  Tomography  – Computed  Tomography  (PET-CT)  is  routinely  utilized  in
the  management  of  melanoma,  either  as a part  of staging  workup  or during  surveillance.  Since  melanomas
have  a  high  metastatic  potential,  any FDG  avid  lesion  is  considered  suspicious  for  recurrence.  We  report
a  case  of a FDG  avid  lesion,  diagnosed  during  melanoma  surveillance,  its  management  and  review  of
literature.
PRESENTATION  OF CASE:  A 58  year-old-male  underwent  wide  local  excision  for melanoma  of  the  left  cheek,
and  one  year  post-operatively  a PET-CT  that revealed  a hypermetabolic  focus  in his right  subscapularis
muscle,  which  upon  resection  was  diagnosed  as Pigmented  Villonodular  Synovitis  (PVNS).
DISCUSSION: PVNS  is  a rare benign  giant  cell  tumor  that  requires  no additional  treatment  in asymptomatic
individuals.  PET-CT  is used  for  staging  and  surveillance  of numerous  malignancies,  including  melanoma.
A  hypermetabolic  lesion  on  a PET-CT  scan  in  the  setting  of malignancy  is always  suspicious  for recurrence.
CONCLUSION:  The  surgeon  is reminded  of  a  uncommon  benign  FDG  avid  lesion.  Typical  location,  non-
speciﬁc  symptoms  and  characteristic  imaging  ﬁndings  help  cue  in  the diagnosis  of  PVNS  and  a  tissue
diagnosis  will  establish  the  diagnosis,  thus  avoiding  unnecessarily  aggressive  surgical  management.
© 2014 The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  . Introduction
Skin cancer accounts for over 40% of all malignancies diag-
osed in the United States, and its incidence is increasing. Overall,
elanoma is it is the eighth most common cancer diagnosed in the
nited States, and although it accounts for only 4–5% of all skin can-
er diagnoses it causes the majority of all skin cancer deaths, and
ith advances in treatment the proportion of melanoma survivors
re on a rise. Detection of cancer recurrence with a combina-
ion of physical exam and imaging studies is a key component of
elanoma surveillance. Although early detection and wide local
xcision of the primary lesion have resulted in much improved sur-
ival rates for patients with melanoma, screening for recurrence is
n essential part of any treatment strategy.
PET-CT is often used to stage melanoma patients prior to their
nitial resection and to follow select patients for recurrence. In
his report, we describe a case of Pigmented Villonodular Synovitis
PVNS) which is an FDG avid lesion and was detected on PET CT dur-
ng routine melanoma surveillance. PVNS is FDG avid on PET-CT and
as been known to cause false positive PET-CT reads,[1] yet a review
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210-2612 © 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Aof the literature reveals few published cases of PVNS masquerading
as melanoma, none in the surgical literature.[2,3]
2. Presentation of case
A  58-year-old male presented to his primary care physician
with a concerning nevus of his left cheek. Punch biopsy revealed
a 0.55 mm thick melanoma, for which he received a wide local
excision. Final pathology revealed melanoma in situ, thickness
0.55 mm,  with negative margins and without any ulceration. He
recovered uneventfully from his primary resection. Approximately
1 year after his melanoma resection he received a PET-CT that
showed a hypermetabolic focus in his right subscapularis muscle,
without corresponding abnormality on the CT component of the
exam (Fig. 1).
Although  it is not routine practice to obtain surveillance PET-CT
scans for early stage melanomas, he was  referred to a surgical oncol-
ogist to undergo further workup as a result of the PET-CT ﬁndings.
To further characterize the lesion he underwent an MRI  of the right
shoulder which revealed a homogenously enhancing nodule mea-
suring 1.4 cm × 0.9 cm × 1.1 cm situated deep to the subscapularis
Open access under CC BY-NC-SA license. muscle and anterior to the joint capsule, concerning for metastatic
melanoma (Fig. 2). Given this concern he was taken to the operating
room, where a palpable mass was identiﬁed in the corresponding
location. The mass was  fully resected and pathology revealed PVNS
ssociates Ltd. Open access under CC BY-NC-SA license. 
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Fig. 3. 40× magniﬁcation of PVNS. Histologically PVNS is a papillary villous nodu-
any joint space, and prior to the widespread clinical use of MRI  forig. 1. PET image showing FDG-avid focus in the right subscapularis muscle. The CT
omponent of the image did not reveal any abnormality.
Fig. 3). The patient is currently 5 years post his initial melanoma
iagnosis and remains disease free. Written informed consent was
btained from the patient for publication of this case report and
ccompanying images.
Fig. 2. MRI  showing a round hypermetabolic focus in the right slar  expansion of the synovial membrane where the surface synovial cells overlie a
lobular and sheet-like arrangement of mononuclear rounded and epitheloid cells,
multinucleated osteoclast-like giant cells, and lipid-rich cells.
3. Discussion
An extensive literature review revealed only three published
cases of PVNS presenting in a patient with a diagnosis of malignant
melanoma (Table 1) 1–3. Two  of these cases were diagnosed while
the patient was  undergoing their initial staging workup at the time
of their melanoma diagnosis, and in the third, the interval between
the melanoma diagnosis and the PVNS diagnosis is not reported. In
all reported cases, the location of the primary melanoma, as well as
the location of the PVNS, is variable (Table 1). Including our patient,
the primary melanomas arose in the cheek, the back, and the per-
ineum, while the PVNS was  found in each knee, the acetabulum, and
the shoulder. All of these patients underwent surgical procedures
to obtain tissue diagnoses on these presumed metastatic lesions,
only to ﬁnd these lesions were benign.
Pigmented Villonodular Synovitis (PVNS) is a rare benign giant
cell tumor of the tendon sheath that is usually asymptomatic but
can present with pain, swelling, and decreased range of move-
ment in the affected joint. PVNS most commonly presents in young
adults with non-speciﬁc symptoms of intermittent pain and joint
swelling, and when it is diagnosed as a localized lesion excision is
curative. Although most common in the knee, PVNS can occur injoint pain was  often diagnosed late.[4] On MRI  PVNS appears as an
intraarticular nodular mass with low signal intensity on T1 and T2,
in contrast to the low T1 and moderately high T2 intensity seen with
ubscapularis muscle concerning for metastatic melanoma.
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able  1
linical characteristics of patients with PVNS and melanoma reported in literature.
Patient Age Primary site aPVNS site Interval between melanoma and aPVNS Source
1 58 M L cheek R shoulder 1 year
2  47 M L cheek R knee Unknown Clin Nucl Med  20072
3 51 M Perineum L knee Simultaneous Ann Diagn Pathol 20033
4 49 F L back L acetabulum Simultaneous Clin Nucl Med  20031
a PVNS: primary villonodular synovitis.
elanoma metastases. As PVNS and metastatic melanoma require
astly different treatment regimens, it is important for the surgeon
o consider PVNS as a differential for melanoma especially in cases
hen PET-CT identiﬁes possible metastatic spread to the joints.
The utility of Positron Emission Tomography – Computed
omography (PET-CT) to monitor clinically asymptomatic
elanoma patients for metastatic recurrence is well described, and
ny resectable FDG avid lesions that are identiﬁed are assumed to
equire aggressive surgical management. Current NCCN guidelines
ecommend that patients with Stage IIB or greater melanoma
>2.01 mm thickness) receive routine imaging (chest X-ray, CT,
r PET-CT) every 4–12 months to surveil for recurrence; patients
ith lower stage melanoma do not require routine surveillance in
he absence of symptoms suggestive of recurrence.[5] Of course,
atients who develop symptoms concerning for metastasis should
lways be investigated at the discretion of the attending physician.
. Conclusion
PET-CT is used for staging and surveillance of numerous malig-
ancies, including melanoma. An FDG-avid lesion on a PET-CT scan
n the setting of a known malignancy is always suspicious for
ecurrence and warrants an aggressive workup, but the surgeon
s reminded that not all FDG-avid lesions are metastases. In our
ase the presumed metastasis in the joint was identiﬁed as PVNS
n ﬁnal pathology. This uncommon, and benign, FDG-avid lesion
equires no additional treatment in asymptomatic individuals, thus
voiding signiﬁcant morbidity and distress to the patients. Typical
ocation, nonspeciﬁc symptoms and characteristic imaging ﬁndings
elp cue in the diagnosis of PVNS and a tissue diagnosis will estab-
ish the diagnosis, thus avoiding unnecessarily aggressive surgical
anagement.
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Key learning points
FDG-avid lesions in atypical locations for metastases require further workup before metastasectomy.
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